clinical trial · NCT04028492
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Idiopathic GastroparesisDiabetic GastroparesisGastroparesisTradipitantPlaceboOpen Label Tradipitant
brief summary
To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
started
Aug 20, 2019
primary completion
Feb 21, 2025
completion
Feb 21, 2025
last updated
Jul 24, 2025
official title
VP-VLY-686-3301: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Iii Study To Assess The Efficacy Of Tradipitant In Relieving Symptoms Of Gastroparesis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol